On twenty five August, Japanese authorities announced that they'd be willing to supply usage of an anti-influenza drug now under growth termed favipiravir to test to treat EVD individuals. ICAP team embedded while in the Ministry of Overall health made a curriculum and training resources, then educated learn trainers in https://hackmd.io/@SoV_yEzmSJeQv3CLogOPFw/HJShJNOe2